Alzheimer’s drug decision unsurprisingly splits experts
WASHINGTON D.C. : US regulators have approved the first ever medication for Alzheimer’s disease aimed… read more
Cogstate jumps 51pc on Alzheimer’s drug news
MELBOURNE: Shares in Cogstate, a neuroscience technology company backed by the Myer family, rocketed 60… read more
New Alzheimer’s drug unlikely to be approved in Australia
CANBERRA: A controversial new drug that has offered hope to Alzheimer’s sufferers by slowing cognitive… read more
